Keyphrases
Cataract Surgery
24%
Cellularity
25%
Complication Outcome
17%
Cryotherapy
25%
Early Surgery
17%
Epiretinal Membrane
32%
Fellow Eye
18%
Floaters
50%
Forceps
38%
Germline mutation
17%
Hyalocytes
25%
Internal Limiting Membrane
21%
Intravitreal Antibiotics
17%
Intravitreal Dexamethasone
17%
Juxtapapillary
35%
Laser Photocoagulation
24%
Laser Therapy
20%
Late Development
19%
Mutation Carriers
17%
Ocular Toxicity Studies
17%
Pathophysiology
20%
Pediatric Patients
17%
Posterior Vitreous Detachment
60%
Proliferative Vitreoretinopathy
65%
Prophylactic Laser
17%
Rabbit Eye
17%
Randomized Placebo-controlled Trial
17%
Retina
25%
Retinal Break
35%
Retinal Detachment
55%
Retinal Detachment Surgery
22%
Retinal Hemangioblastoma
87%
Retinal Surfaces
37%
Retinal Tear
49%
Retinal Vein
21%
Rhegmatogenous Retinal Detachment
40%
Superiority Trial
17%
Surgical Treatment
25%
Symptom Awareness
17%
Treatment Options
32%
Treatment Outcome
17%
Trypan Blue
33%
Visual Acuity
39%
Visual Outcome
21%
Vitrectomy
62%
Vitreoretinal Surgery
36%
Vitreoschisis-induced Vitreous Cortex Remnants
46%
Vitreous Cortex Remnants
51%
Vitreous Hemorrhage
31%
Von Hippel-Lindau
19%
Medicine and Dentistry
Agents Acting on the Eye
17%
Alteplase
13%
Antibiotics
17%
Best Corrected Visual Acuity
12%
Cannulation
26%
Cataract Surgery
26%
Central Retinal Vein Occlusion
17%
Cryotherapy
25%
Dexamethasone
17%
Diathermy
35%
Endophthalmitis
17%
Epiretinal Membrane
34%
Ex Vivo
17%
Eye Toxicity
17%
Flushing
36%
Glaucoma
17%
Hamartoma
17%
Hemangioblastoma
70%
Histopathology
17%
Implant
17%
Laser Coagulation
28%
Low Level Laser Therapy
20%
Neoplasm
14%
Optical Coherence Tomography Angiography
17%
Pathophysiology
21%
Pediatrics Patient
17%
Placebo
17%
Pooled Analysis
14%
Posterior Vitreous Detachment
67%
Prevalence
17%
Proliferative Vitreoretinopathy
78%
Randomized Clinical Trial
17%
Retina Tear
55%
Retinal Break
35%
Retinal Detachment
84%
Retinal Haemorrhage
15%
Retinal Pigment Epithelium
17%
Retinopexy
17%
Surgery
41%
Surgical Technique
16%
Symptom
52%
Systematic Review
35%
Tissue Plasminogen Activator
17%
Trypan Blue
37%
Visual Acuity
37%
Visual Impairment
15%
Vitrectomy
63%
Vitreoretinal Surgery
33%
Vitreous
100%
Vitreous Hemorrhage
45%
